Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.98 % |
3 Month Return | -15.41 % |
1 Year Return | -19.4 % |
Market Stats | |
Previous Close | ₹67.50 |
Open | ₹68.40 |
Volume | 3,668.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹140.38Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹140.38 Cr |
P/B Ratio | 1.98 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 4.97 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹140.38 Cr | 39.08% | 0.51 | NA | NA | |
NA | ₹2,619.80 Cr | 361.65% | 0.82 | NA | NA | |
HOLD | ₹24,440.70 Cr | 19.25% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
NA | ₹220.90 Cr | 22.21% | 0.56 | ₹3 Cr | ₹47 Cr | |
NA | ₹113.41 Cr | 5.32% | 0.50 | ₹45 Cr | ₹59 Cr |
Organisation | Lotus Eye Hospital & Institute Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Lotus Eye Hospital & Institute Ltd
Lotus Eye-care Hospital and Institute Touches 52-Week Low - 05 Mar, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 59.75% to 59.94% in Sep 2024 quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 168.0% return, outperforming this stock by 140.8%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 72.4% return, outperforming this stock by 91.8%
Price Dip
In the last 1 year, LOTUSEYE stock has moved down by -19.4%
Promoter Holding Down
Promoters have decreased holdings from 40.24% to 40.03% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 40.03% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 59.94% | 0.31 | |
Others | 0.03% | 266.67 |
Lotus Eye Hospital & Institute Ltd’s net profit fell -88.24% since last year same period to ₹0.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated -83.87% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.48%.
Read More about DividendsBearish
Neutral
Bullish
Lotus Eye Hospital & Institute Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lotus Eye Hospital & Institute Ltd (LOTUSEYE) share price today is ₹66.19
Lotus Eye Hospital & Institute Ltd is listed on NSE
Lotus Eye Hospital & Institute Ltd is listed on BSE
Today’s traded volume of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is 3,668.00.
Today’s market capitalisation of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is ₹140.38Cr.
Lotus Eye Hospital & Institute Ltd(LOTUSEYE | Price |
---|---|
52 Week High | ₹95.6 |
52 Week Low | ₹48.5 |
Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹66.19. It is down -30.76% from its 52 Week High price of ₹95.6
Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹66.19. It is up 36.47% from its 52 Week Low price of ₹48.5
Lotus Eye Hospital & Institute Ltd(LOTUSEYE | Returns |
---|---|
1 Day Returns | -1.31% |
1 Month Returns | -2.98% |
3 Month Returns | -15.41% |
1 Year Returns | -19.4% |